Digoxin After Acute Heart Failure (DIG-DICA)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT07321509

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Hospital General de Agudos "Dr. Cosme Argerich" (from the registry)
Registry
  • NCT NCT07321509
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Argentina (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07321509. Randomized; no masking; primary purpose treatment. Start 2025-12-16 (actual); primary completion 2027-12-16 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Digoxin After Acute Heart Failure (DIG-DICA)
Acronym
DIG-DICA
Condition
Acute Heart Failure (AHF)
Intervention (Other)
Usual Care
Intervention (Drug)
Digoxin
Lead sponsor
Hospital General de Agudos "Dr. Cosme Argerich" (class: other)

Record details

Record id
cardio:ct-nct07321509
Content hash
711c14e4a15e93f46727e6c9110521a3c4a35f40c034aa468969af661558da94